Status:
ACTIVE_NOT_RECRUITING
Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate
Lead Sponsor:
Sanliurfa Education and Research Hospital
Conditions:
Unexpected Fetal Cardiac Effects of Nifedipine and MgSO4
Eligibility:
FEMALE
18-50 years
Brief Summary
The potential unexpected effects of nifedipine and MgSO4, the tocolytic agents used for the indication of preterm labor, on fetal heart will be determined. In this study, the fetal echocardiographic f...
Detailed Description
This study will include pregnancies at 24-34 weeks of gestation that are using nifedipine and MgSO4 for tocolysis. Fetal echocardiographic findings of these pregnancies will be recorded
Eligibility Criteria
Inclusion
- Patients with preterm labor indication at 24-34 weeks of gestation
- Treated with nifedipine or MgSO4 for tocolysis
Exclusion
- Multiple pregnancy
- premature rupture of membranes
- Chorioamnionitis
- Placental abruption
- Severe fetal growth restriction
- Congenital anomalies of the fetus
- Preeclampsia
- Oligohydramnios
- Maternal diabetes
- Contraindications for the use of nifedipine and/or MgSO4 in the mother
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06904534
Start Date
January 1 2025
End Date
November 30 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Şanlıurfa Training and Research Hospital
Sanliurfa, Turkey (Türkiye), 63100